Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapy-Reference-Cited by-同舟云学术

Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapy

Published:2010-04-06 Issue:12 Volume:116 Page:3025-3033
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kim Seung Tae,Lee Jeeyun,Kim Jeong-hoon,Won Young-Woong,Sun Jong-Mu,Yun Jina,Park Yeon Hee,Ahn Jin Seok,Park Keunchil,Ahn Myung-Ju

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Cancer statistics, 2002;Jemal;CA Cancer J Clin.,2002

2. Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer;Sasaki;J Cancer Res Clin Oncol.,2008

3. Comparison of 4 chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med.,2002

4. Treatment of metastatic non-small cell lung cancer;van Zandwijk;Curr Opin Oncol.,1996

5. Efficacy of administration of weekly docetaxel combined with platinum as a first-line treatment for patients with advanced non-small cell lung cancer;Kim;Korea J Med.,2007

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A physicochemical and spectroscopic characterization of novel erlotinib conjugates with platinum nanoparticles;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2022-12

2. Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer;Pharmaceutical Development and Technology;2021-07-05

3. Spectroscopic insights into the effect of pH, temperature, and stabilizer on erlotinib adsorption behavior onto Ag nanosurface;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2020-03

4. Efficacy and Safety of Capecitabine Alone or in Combination in Advanced Metastatic Breast Cancer Patients Previously Treated with Anthracycline and Taxane: A Systematic Review and Meta-Analysis;Oncology Research and Treatment;2020

5. Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations;Oncology Research and Treatment;2020